Yi Chang
Direktor/Vorstandsmitglied bei NONGFU SPRING CO., LTD.
Aktive Positionen von Yi Chang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NONGFU SPRING CO., LTD. | Direktor/Vorstandsmitglied | 06.03.2020 | - |
| Independent Dir/Board Member | 06.03.2020 | - | |
| COWEALTH MEDICAL CHINA CO.,LTD. | Direktor/Vorstandsmitglied | 22.03.2019 | - |
| Independent Dir/Board Member | 22.03.2019 | - | |
| China Institute of Internal Audit | Corporate Officer/Principal | - | - |
| Asian Development Bank China | Corporate Officer/Principal | - | - |
| Shanghai Advanced Institute of Finance | Corporate Officer/Principal | 01.07.2018 | - |
| Grant Thornton LLP (China) | Corporate Officer/Principal | - | - |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Direktor/Vorstandsmitglied | 19.01.2021 | - |
| Independent Dir/Board Member | 19.01.2021 | - |
Karriereverlauf von Yi Chang
Ehemalige bekannte Positionen von Yi Chang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SIPAI HEALTH TECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | 30.07.2021 | 21.05.2024 |
| Independent Dir/Board Member | 30.07.2021 | 21.05.2024 | |
| LAKESHORE BIOPHARMA CO., LTD | Direktor/Vorstandsmitglied | - | 09.12.2023 |
| Independent Dir/Board Member | - | 09.12.2023 | |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░ ░░ ░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░ ░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Ausbildung von Yi Chang
| National Taiwan University | Undergraduate Degree |
| University of Missouri | Graduate Degree |
| Texas Tech University | Doctorate Degree |
Statistik
International
| China | 12 |
| Vereinigte Staaten | 4 |
| Taiwan | 2 |
Operativ
| Corporate Officer/Principal | 7 |
| Director/Board Member | 5 |
| Independent Dir/Board Member | 5 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Consumer Non-Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NONGFU SPRING CO., LTD. | Consumer Non-Durables |
| SIPAI HEALTH TECHNOLOGY CO., LTD. | Retail Trade |
| COWEALTH MEDICAL CHINA CO.,LTD. | Health Technology |
| LAKESHORE BIOPHARMA CO., LTD | Health Technology |
| Private Unternehmen | 7 |
|---|---|
| China Institute of Internal Audit | |
| Asian Development Bank China | Government |
Marcum Asia CPAs LLP
 Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Commercial Services |
| Grant Thornton LLP (China) | |
| Ernst & Young (China) | |
| Texas State Board of Public Accountancy | |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |
